Aaron Cohen, MD
Internal Medicine · Atlantis, FLNPI 1639464019
Payments from drug & device makers
Across 370 payments — averaging $13,705 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2.4M
- Indivior Inc.$2.4M
- Seqirus USA Inc$306K
- Novo Nordisk$334
- Lilly USA, LLC$285
- Astellas Pharma US Inc$272
- plus $2K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 67 | $2,399,132 |
| Indivior Inc. | 29 | $2,363,162 |
| Seqirus USA Inc | 141 | $305,757 |
| Novo Nordisk | 13 | $334 |
| Lilly USA, LLC | 19 | $285 |
| Astellas Pharma US Inc | 12 | $272 |
| Exact Sciences | 10 | $223 |
| Amgen | 9 | $199 |
| Abbott | 9 | $183 |
| Boehringer Ingelheim | 7 | $182 |
| Johnson & Johnson | 10 | $179 |
| AstraZeneca | 2 | $143 |
| Pfizer | 7 | $140 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| Novartis | 4 | $73 |
| AbbVie | 4 | $65 |
| Boston Scientific | 3 | $57 |
| Medtronic | 1 | $52 |
| GSK | 3 | $51 |
| Bayer | 2 | $50 |
| Smith+Nephew | 1 | $44 |
| Corcept Therapeutics | 1 | $28 |
| Philips North America LLC | 1 | $25 |
| Biosense Webster, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Redhill Biopharma Inc. | 1 | $20 |
| Gilead | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Sobi, Inc | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Medexus Pharma, Inc. | 1 | $12 |
How this compares
$5,070,929 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Atlantis
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.